Male patients with diagnoses of both breast cancer and prostate cancer

Breast Journal

Volumn 9, Issue 3, 2003, Pages 208-212

  Leibowitz, Stacey B ^a,b   Garber, Judy E ^a   Fox, Edward A ^a   Loda, Massimo ^a   Kaufman, Donald S ^a   Kantoff, Philip W ^a   Oh, William K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

BRCA 2; Breast cancer; Metachronous; Prostate cancer; Tamoxifen

Indexed keywords

ACID PHOSPHATASE; BICALUTAMIDE; ESTROGEN RECEPTOR; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BASAL CELL CARCINOMA; BONE SCINTISCANNING; BREAST CANCER; BREAST DUCTAL CARCINOMA IN SITU; BREAST LOBULAR CARCINOMA IN SITU; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DNA SEQUENCE; FAMILY HISTORY; FATIGUE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC LINKAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; MORTALITY; ONCOGENE; ONSET AGE; PROSTATE CANCER; RELATIVE; RETROSPECTIVE STUDY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS, MALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASSACHUSETTS; MEDICAL RECORDS; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0037736517     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2003.09312.x     Document Type: Article

References (17)

1. Sobin LH, Sherif M. Relation between male breast cancer and prostate cancer. Br J Cancer 1980;42:787-90.
2. Coffey DS. Similarities of prostate and breast cancer: evolution, diet, estrogens. Urology 2001;57(4 suppl 1):31-38.
3. Gao X, Zacharek A, Salkowski A, et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002-5.
4. Sigurdsson S, Thorlacius S, Tomasson J, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997;75:758-61.
5. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-19.
6. Tajika M, Tuchiya T, Yasuda M, et al. A male case of synchronous double cancers of the breast and prostate. Intern Med 1994;33:31-35.
7. Schlappack OK, Braun O, Maier U. Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma. Cancer Detect Prev 1986;9:319-22.
8. Ozet A, Yavuz AA, Komurcu S, et al. Bilateral male breast cancer and prostate cancer: a case report. Jpn J Clin Oncol 2000;30:188-90.
9. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998;19:365-96.
10. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
11. Jaiyesimi IA, Buzdar AU, Sahin AA, et al. Carcinoma of the male breast. Ann Intern Med 1992;117:771-77.
12. Hecht JR, Winchester DJ. Male breast cancer. Am J Clin Pathol 1994;102(4 suppl 1):S25-S30.
13. McLachlan SA, Erlichman C, Liu FF, et al. Male breast cancer: an 11 year review of 66 patients. Breast Cancer Res Treat 1996;40:225-30.
14. Bergan RC, Reed E, Myers CE, et al. A phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. Clin Cancer Res 1999;5:2366-73.
15. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-16.
16. Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120-28.
17. Diez O, Cortes J, Domenech M, et al. BRCA2 germ-line mutations in Spanish male breast cancer patients. Ann Oncol 2000;11:81-84.